PTYLTD
    • Free Reports
    • Videos
  • Pricing
  • About us
  • Contact us
  • Login | Sign up
PTYLTD

Free Reports

Videos

Pricing

About us

Contact us

  • Home
  • Insights into ASX Stocks
  • By Topic

By Topic

EchoIQ (ASX: EIQ)

EchoIQ (ASX: EIQ) Surges to Record Highs as Share Price Momentum Accelerates

May 4, 2026
Proactive Equities Team

EchoIQ (ASX: EIQ) has surged on AI-driven healthcare momentum and US expansion, backed by strong clinical results and partnerships. While technically bullish, the stock is consolidating after a sharp rally, with key support at $0.92–$0.95 and resistance near $1.00.

Liontown (ASX: LTR)

How much higher can the breakout in Liontown's (ASX: LTR) share price take it?

Apr 19, 2026
Proactive Equities Team

Liontown Resources has rallied on stronger lithium prices, improving production at Kathleen Valley, and a healthier balance sheet after reducing debt. Rising EV and battery demand plus new offtake deals have lifted sentiment. The stock is now approaching key resistance around A$2.20, where the next breakout or pullback will likely be decided.

Liontown

Liontown Resources (ASX: LTR): Powering the EV Revolution from Kathleen Valley

Oct 27, 2025
Proactive Equities Team

Liontown Resources (ASX: LTR) is a next-generation lithium developer advancing toward production at its flagship Kathleen Valley Project in Western Australia. With Tier-1 offtake partners and strong financial backing, Liontown is poised to become a key player in the global EV and battery supply chain.

Karoon Energy (ASX: KAR)

Karoon Energy (ASX: KAR): Operational Inflection, Margin Strength and a Two‑Hub Growth Engine

Jul 24, 2026
Proactive Equities Team

Karoon Energy (ASX: KAR) delivers resilient production, strong cash margins and a two‑hub growth pipeline across Brazil and the US Gulf, positioning for higher free cash flow in 2H26 and multi‑year expansion.

BLS Pharmaceuticals (ASX: BLS)

BLS Pharmaceuticals' (ASX: BLS) Shares: Strong Growth Story, Crucial Technical Crossroads

Jul 25, 2026
Proactive Equities Team

BLS Pharmaceuticals has rapidly transformed into a profitable regulated-medicines manufacturer, supported by strong revenue growth, controlled-substance licences and international expansion. While FY26 guidance remains ambitious, bearish RSI divergence suggests traders should monitor key support levels closely.

Larvotto Resources

Larvotto Resources (ASX: LRV): Building Australia’s Next Antimony–Gold Producer

Oct 29, 2025
Proactive Equities Team

Larvotto Resources Limited (ASX: LRV) is an Australian emerging mining company transitioning from explorer to near-term producer. Its flagship asset, the Hillgrove Antimony–Gold Project in New South Wales, positions the company as a potential supplier of two strategically important metals: gold—a monetary safe-haven—and antimony, a critical mineral used in batteries, semiconductors, and defense alloys.

...

 

Proactive Equities

At Proactive Equities, we combine deep market expertise with rigorous analysis to deliver stock recommendations you can trust. Our team of seasoned analysts continuously monitor global markets, economic trends, and company fundamentals to identify high-potential investment and trade opportunities.

Company

Home
Pricing
Contact Us
About Us

Resources

ASX Insights
Investing Basics
Videos

Links

Privacy Policy
Terms and Conditions
Product Disclosure Statement

Proactive Equities Pty Ltd (ACN: 687 232 471) is a Corporate Authorised Representative (AFSR No. 001318293) of Australia National Investment Group Pty Ltd (ABN: 40 636 343 630), which holds an Australian Financial Services Licence (AFSL no. 522028). The information on this website is general information only and does not constitute personal financial advice. We have not taken the individual circumstances, financial objectives or needs of any investor into account when preparing this information. Investors should consider their circumstances and the relevant PDS for any investment and obtain professional financial and tax advice before making any investment decision. The information on this website is not a recommendation to make any investment or to adopt any particular investment strategy. You should make your own professional assessment of the suitability of this information, relying on your own inquiries. Investments in securities are subject to investment risk. Investment value may go down as wellas up, and investors may not get back the full amount originally invested. Risks include: the investment objective may not be achieved, share market and other market risk, liquidity risk, and currency risk with international investments. Any past performance shown is not an indication of future performance. Commission and other costs charged by executing broker are not considered when calculating past performance. To the extent permitted by law Proactive Equities Pty Ltd accepts no liability for any errors or omissions in, or loss from reliance on the information in this website.

1...111213...48
Page 12 of 48